Sg3 Management, LLC Crispr Therapeutics Ag Put Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.65 Million - $2.35 Million	15,000 Added 125.0%	27,000 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $2.77 Million - $4.45 Million	-27,500 Reduced 69.62%	12,000 $1.94 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $3.27 Million - $6.2 Million	29,500 Added 295.0%	39,500 $4.81 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $796,700 - $1.73 Million	10,000 New	10,000 $1.53 Million
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $5.5 Million - $7.04 Million	-70,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $2.7 Million - $5.32 Million	70,000 New	70,000 $5.14 Million

503

57M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.